EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES ADEQUATELY CONTROLLED DIABETES AND PROTEINURIA: A ONE YEAR RETROSPECTIVE OBSERVATIONAL STUDY.
Back
Abstract Number
WCN23-0521
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES ADEQUATELY CONTROLLED DIABETES AND PROTEINURIA: A ONE YEAR RETROSPECTIVE OBSERVATIONAL STUDY.
Co-authors
Akl, A.I.(1)*;Almaghrabi, A.T.(2);Alzahrani, E.A.(3);Qorban, G.N.(3);Ismail, R.T.(3);Binsalman, S.A.(2);Algrigri, A.H.(2);Alhusaini, A.A.A.(2);Aldhaheri, F.(2);Waqas, D.(4);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Dr.Soliman Fakeeh Hospital, Im/Adult Nephrology, Jeddah, Saudi Arabia;(2)Dr. Soliman Fakeeh Hospital, Internal Medicine, Jeddah, Saudi Arabia;(3)Dr. Soliman Fakeeh Hospital, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia;(4)Fakeeh College Of Medical Sciences, Biology, Jeddah, Saudi Arabia;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/ec91db606720985ed0b69e210e2840b1.pdf
Audio File
https://storage.unitedwebnetwork.com/files/1041/ff08d940e091aadbda898e1078aacaa4.mp3
if any